Gene · 1947
EFNB1: ephrin B1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. EFNB1: ephrin B1. Genes, record 1947. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1947
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P98172 | Ephrin-B1 | 346 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents61
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 45100 | P98172 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 228 | P98172 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1362 | P98172 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1362 | P98172 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 228 | P98172 | Espacenet |
| JP 2025506727 A | 2025-03-13 | 63 | P98172 | Espacenet |
| EP 4511052 A2 | 2025-02-26 | 58 | P98172 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 27678 | P98172 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 3041 | P98172 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 130649 | P98172 | Espacenet |
1 to 10 of 61
See all 61 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,049
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | EFNB1 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC010958 | Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| ZIABC010006 | Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways | 5 | 2025 |
| R01DA022727 | Cell-Contact Mediated Mechanisms Assembling Synapses (R01DA022727) | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 3 | 2025 |
| P30ES007033 | University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment | 3 | 2025 |
| P30EY008126 | Core Grant in Vision Research | 3 | 2025 |
| T32AI007647 | Training Program in Mechanisms of Virus-Host Interactions | 3 | 2025 |
1 to 10 of 1,049Source NIH's project files
See all 1,049 nih grantsPapers1,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and genetic features of syndromic craniosynostosis in 18 Chinese probands: novel candidate genes and phenotypes of known pathogenic genes. | Front Genet | 2026 | 42609909 | PubTator, text mining | PubMed |
| Elucidating the Activity of E-Lian Granule in Alleviating Chronic Atrophic Gastritis: Insights from Network Pharmacology, Molecular Docking, and Experimental Validation. | Curr Comput Aided Drug Des | 2026 | 42576526 | PubTator, text mining | PubMed |
| The middle cerebral artery early branches classification (MCA-EB): a novel imaging-based approach. | Front Neurol | 2026 | 42488394 | PubTator, text mining | PubMed |
| Host heterogeneity shapes clonal selection and organotropism in an extranodal lymphoma mouse model. | Cell Death Dis | 2026 | 42431866 | PubTator, text mining | PubMed |
| Physical interaction with Ephrin B1 promotes CXCR4 intracellular localization and oncogenic potential. | Cell Mol Life Sci | 2026 | 42340382 | PubTator, text mining | PubMed |
| Evidence-based classification of genes implicated in craniosynostosis disorders using the ClinGen curation framework. | Genet Med | 2026 | 42059179 | PubTator, text mining | PubMed |
| Clinical and Neurodevelopmental Course in a Case of EFNB1-Related Craniofrontonasal Syndrome With Unrepaired Craniosynostosis. | Mol Genet Genomic Med | 2026 | 42026842 | PubTator, text mining | PubMed |
| From brown to white: Brown adipose tissue endothelial cells whiten in culture conditions. | Mol Metab | 2026 | 41831567 | PubTator, text mining | PubMed |
| EPHA2-Ephrin-B1 cis-interaction drives an oncogenic reverse signaling, leading to the recurrence of oral cancer. | Cell Commun Signal | 2026 | 41814365 | PubTator, text mining | PubMed |
| Human milk oligosaccharides promote synaptogenesis and neurite outgrowth in human cortical organoids. | Biochem Biophys Rep | 2026 | 41799697 | PubTator, text mining | PubMed |
1 to 10 of 1,342
See all 1,342 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1947
GET https://conductscience.org/api/genes/v1/1947/patents?page=2